• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS MENTOR MEMORYGEL BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS MENTOR MEMORYGEL BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number 3542257
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 04/08/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: material rupture, shape change, hardening.Manufacturer¿s reference number: (b)(4).
 
Event or Problem Description
It was reported that a (b)(6) caucasian female patient, who's undergone breast augmentation revision with a 225cc mentor memorygel breast implant on the left breast, suffered left breast implant rupture, shape change, and intermittent hardening, post-procedure.As a result, the patient underwent bilateral removal and replacement with non-mentor devices on (b)(6) 2021.
 
Additional Manufacturer Narrative
On june 28, 2021, mentor received additional information indicating that the correct date of implantation was on (b)(6) 1999.Manufacturer¿s reference number: (b)(4).
 
Additional Manufacturer Narrative
On july 22, 2021, mentor received additional information indicating that during the revision surgery on (b)(6) 2021, the left breast implant was identified to have completely disintegrated and was discarded.The complaint device has been discarded.As a result, no product failure analysis can be conducted, and device malfunction cannot be confirmed.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MENTOR MEMORYGEL BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
MDR Report Key12094434
Report Number1645337-2021-07384
Device Sequence Number17334712
Product Code FTR
UDI-Device Identifier00081317000648
UDI-Public00081317000648
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P030053
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year1999
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/29/2004
Device Model Number3542257
Device Catalogue Number3542257
Device Lot Number189238
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 06/10/2021
Supplement Date Received by Manufacturer06/28/2021
07/22/2021
Initial Report FDA Received Date06/30/2021
Supplement Report FDA Received Date07/12/2021
08/03/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age40 YR
-
-